Cargando…
Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus
New potential drugs based on vanadium are being developed as possible treatments for diabetes mellitus (DM) and its complications. In this regard, our working group developed metforminium decavanadate (MetfDeca), a compound with hypoglycemic and hypolipidemic properties. MetfDeca was evaluated in mo...
Autores principales: | Treviño, Samuel, Velázquez-Vázquez, Denisse, Sánchez-Lara, Eduardo, Diaz-Fonseca, Alfonso, Flores-Hernandez, José Ángel, Pérez-Benítez, Aarón, Brambila-Colombres, Eduardo, González-Vergara, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826921/ https://www.ncbi.nlm.nih.gov/pubmed/27119007 http://dx.doi.org/10.1155/2016/6058705 |
Ejemplares similares
-
Pharmacological and Toxicological Threshold of Bisammonium Tetrakis 4-(N,N-Dimethylamino)pyridinium Decavanadate in a Rat Model of Metabolic Syndrome and Insulin Resistance
por: Treviño, Samuel, et al.
Publicado: (2018) -
Decavanadate Salts of Cytosine and Metformin: A Combined Experimental-Theoretical Study of Potential Metallodrugs Against Diabetes and Cancer
por: Sánchez-Lara, Eduardo, et al.
Publicado: (2018) -
Nonapiperidinium monohydrogen decavanadate tetranitrate
por: Graia, Mohsen, et al.
Publicado: (2009) -
Mercuric-sulphide based metallopharmaceutical formulation as an alternative therapeutic to combat viral and multidrug-resistant (MDR) bacterial infections
por: Malarvizhi, Kootharasan, et al.
Publicado: (2023) -
Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus
por: Treviño, Samuel, et al.
Publicado: (2018)